ImmunoPrecise Antibodies Ltd (IPA)
0.46
-0.02
(-3.62%)
USD |
NASDAQ |
Nov 14, 16:00
0.50
+0.04
(+8.70%)
After-Hours: 20:00
ImmunoPrecise Antibodies Total Assets (Quarterly): 42.81M for July 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 42.81M |
| April 30, 2024 | 43.89M |
| January 31, 2024 | 58.71M |
| October 31, 2023 | 54.67M |
| July 31, 2023 | 57.77M |
| April 30, 2023 | 56.97M |
| January 31, 2023 | 61.59M |
| October 31, 2022 | 60.81M |
| July 31, 2022 | 61.67M |
| April 30, 2022 | 72.36M |
| January 31, 2022 | 44.23M |
| October 31, 2021 | 48.68M |
| July 31, 2021 | 51.64M |
| April 30, 2021 | 54.54M |
| January 31, 2021 | 34.11M |
| October 31, 2020 | 32.80M |
| July 31, 2020 | 24.91M |
| April 30, 2020 | 19.48M |
| January 31, 2020 | 19.34M |
| October 31, 2019 | 20.03M |
| July 31, 2019 | 21.19M |
| April 30, 2019 | 21.15M |
| January 31, 2019 | 22.02M |
| October 31, 2018 | 23.66M |
| July 31, 2018 | 18.33M |
| Date | Value |
|---|---|
| April 30, 2018 | 19.13M |
| January 31, 2018 | 10.60M |
| October 31, 2017 | 10.33M |
| July 31, 2017 | 2.413M |
| April 30, 2017 | 2.882M |
| January 31, 2017 | 3.492M |
| September 30, 2016 | 0.3961M |
| June 30, 2016 | 0.018M |
| March 31, 2016 | 0.0199M |
| December 31, 2015 | 0.0111M |
| September 30, 2015 | 0.0147M |
| June 30, 2015 | 0.0251M |
| March 31, 2015 | 0.0353M |
| December 31, 2014 | 0.0397M |
| September 30, 2014 | 0.0448M |
| June 30, 2014 | 0.0958M |
| March 31, 2014 | 0.117M |
| December 31, 2013 | 0.1336M |
| September 30, 2013 | 0.1786M |
| June 30, 2013 | 0.0357M |
| March 31, 2013 | 0.0374M |
| December 31, 2012 | 0.0502M |
| September 30, 2012 | 0.0742M |
| June 30, 2012 | 0.079M |
| March 31, 2012 | 0.1064M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
19.34M
Minimum
Jan 2020
72.36M
Maximum
Apr 2022
47.42M
Average
51.64M
Median
Jul 2021
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 549.36M |
| Edesa Biotech Inc | 5.228M |
| Lexaria Bioscience Corp | 10.02M |
| Xenon Pharmaceuticals Inc | 884.01M |
| ESSA Pharma Inc | 132.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.09M |
| Shareholders Equity (Quarterly) | 23.72M |
| Debt to Equity Ratio | 0.0791 |
| Current Ratio | 0.9862 |
| Net Debt Paydown Yield | -1.74% |